M&A Deal Summary

Viatris Acquires Merck Generics

On May 12, 2007, Viatris acquired life science company Merck Generics from Merck for 4.9B EUR

Acquisition Highlights
  • This is Viatris’ 2nd transaction in the Life Science sector.
  • This is Viatris’ 2nd largest (disclosed) transaction.
  • This is Viatris’ 1st transaction in Germany.

M&A Deal Summary
Date 2007-05-12
Target Merck Generics
Sector Life Science
Buyer(s) Viatris
Sellers(s) Merck
Deal Type Divestiture
Deal Value 4.9B EUR

Target

Merck Generics

Germany
Merck Generics is a generic and specialty pharmaceutical company.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Viatris

Canonsburg, Pennsylvania, United States
Category Company
Founded 1961
Sector Life Science
Employees33,000
Revenue 15.4B USD (2023)
DESCRIPTION

Viatris is a generic and specialty pharmaceutical company. Viatris offers the industry's broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Viatris was founded in 1961 and is based in Canonsburg, Pennsylvania.

DEAL STATS #
Overall 3 of 13
Sector (Life Science) 2 of 10
Type (Divestiture) 1 of 6
Country (Germany) 1 of 1
Year (2007) 1 of 1
Size (of disclosed) 2 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-08-28 Mylan Laboratories

Secunderabad, India

Mylan Laboratories Limited (Mylan Labs), a subsidiary of U.S.-based Mylan Inc. (Nasdaq: MYL), is one of the world’s largest manufacturers and suppliers of active pharmaceutical ingredients (APIs). Based in Hyderabad, India, Mylan Labs offers more than 150 APIs and intermediates to customers in more than 80 countries across a wide range of therapeutic categories.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-28 Somerset Pharmaceuticals

Tampa,, Florida, United States

Somerset, a proprietary research and development company,Somerset developed EMSAM(R), a transdermal patch for the treatment of major depressive disorder, currently marketed in the United States by Bristol-Myers Squibb.

Buy -

Seller(S) 1

SELLER

Merck

Darmstadt, Germany
Category Company
Founded 1668
Sector Diversified
Employees64,011
Revenue 21.0B EUR (2023)
DESCRIPTION

Merck is a science and technology company in healthcare, life science, and performance materials. Merck develops technologies that improve and enhance life from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.

DEAL STATS #
Overall 3 of 7
Sector (Life Science) 2 of 4
Type (Divestiture) 3 of 7
Country (Germany) 2 of 4
Year (2007) 1 of 1
Size (of disclosed) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-05 Serono S.A.

Darmstadt, Germany

Serono S.A. a biopharmaceutical company, engages in development of prescription medicines of chemical and biological origin in specialist indications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-09 Suzhou Taizhu Technology Development

Taicang, China

Suzhou Taizhu Technology Development Co., Ltd. is a provider of effect pigments for printing, plastics, coating, and cosmetics industries.

Buy -
Mergr

Product

Company

Legal